Searchable abstracts of presentations at key conferences in endocrinology

ea0063oc12.4 | Endocrine Connections 2 | ECE2019

Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France

Pinoche Tiphaine , Mortier Laurent , Scherperel Arnaud , Rudelli Christine Cortet , Merlen Emilie

Ojective: We characterized the onset and follow-up of hypophysitis in a cohort of 612 patients treated for a cancer by antitumoral immunotherapy between june 2010 and may 2017 in CHU Lille, France. Design and patients: 612 patients treated by anti-CTLA4 and or antiPD-1 for melanoma (n=426), lung cancer (n=166), hematological cancer (n=19) or maxillary epidermoid cancer (n=1).Methods: Follow-up of patients treated by im...

ea0041ep21 | Adrenal cortex (to include Cushing's) | ECE2016

Long-term metabolic evolution of a cohort of patients treated for adrenal insufficiency

Coralie Moutarde , Claire Douillard , Catherine Bauters , Christine Cortet , Christine Do Cao , Laurence Leclerc , Emilie Merlen , Pascal Pigny , Jean-Louis Wemeau , Marie-Christine Vantyghem

The aim of this retrospective study was to compare the long-term metabolic evolution of a cohort of patients treated for adrenal insufficiency (AI), and the best biological parameters of a good balance.Seventy patients with AI (mean age 41 years (±16); 60% female) were followed during a median 6-year period (2–16 years): 38 after bilateral adrenalectomy (60% Cushing) and 32 after AI of medical origin (62% polyglandular autoimmune syndrome). BMI...

ea0081p140 | Pituitary and Neuroendocrinology | ECE2022

Efficacy of lanreotide 120 mg primary therapy on tumor shrinkage and ophthalmologic symptoms in acromegaly after one month

Benderradji Hamza , Elise Vernotte , Ares Gustave Soto , Jean Philippe Woillez , Romain Perbet , Melodie-Anne Karnoub , Benoit Soudan , Arnaud Jannin , Assaker Richard , Luc Buee , Prevot Vincent , Claude-Alain Maurage , Pascal Pigny , Marie-Christine Vantyghem , Emilie Merlen , Cortet Rudelli Christine

Introduction: Few studies to date have attempted to evaluate the early efficacy of first-generation somatostatin analogs in somatotroph macroadenomas.Objective: To investigate the short-term efficacy of primary therapy with lanreotide 120 mg on tumor shrinkage and ophthalmologic symptoms in newly diagnosed patients with acromegaly.Design and patients: This single-center retrospective study included 21 patients who were newly diagno...